J.W. Cole Advisors, Inc. Novartis Ag Transaction History

J.W. Cole Advisors, Inc.

$2.33 Billion
Q3 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 6,310 shares of NVS stock, worth $650,497. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,310

Previous 6,053 4.25%

Holding current value

$650,497

Previous $644,000 12.58%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$106.13 - $120.89 $27,275 - $31,068	257 Added 4.25%	6,310 $725,000
Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $24,160 - $28,023	-261 Reduced 4.13%	6,053 $644,000
Q1 2024 Apr 30, 2024	BUY	$95.27 - $108.47 $44,205 - $50,330	464 Added 7.93%	6,314 $610,000
Q4 2023 Jan 31, 2024	SELL	$92.27 - $101.54 $75,107 - $82,653	-814 Reduced 12.21%	5,850 $590,000
Q3 2023 Oct 24, 2023	BUY	$94.73 - $105.13 $8,241 - $9,146	87 Added 1.32%	6,664 $678,000
Q2 2023 Jul 27, 2023	BUY	$92.52 - $104.91 $11,194 - $12,694	121 Added 1.87%	6,577 $663,000
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $24,249 - $28,121	-303 Reduced 4.48%	6,456 $593,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $26,820 - $32,844	355 Added 5.54%	6,759 $613,000
Q3 2022 Oct 31, 2022	BUY	$74.61 - $87.26 $29,172 - $34,118	391 Added 6.5%	6,404 $487,000
Q2 2022 Jul 27, 2022	SELL	$80.52 - $93.75 $4,992 - $5,812	-62 Reduced 1.02%	6,013 $508,000
Q1 2022 Jun 10, 2022	SELL	$80.11 - $90.62 $36.1 Million - $40.9 Million	-450,940 Reduced 98.67%	6,075 $533,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $36.1 Million - $40.9 Million	450,897 Added 7370.01%	457,015 $85,000
Q4 2021 Jan 25, 2022	BUY	$79.7 - $88.13 $2,151 - $2,379	27 Added 0.44%	6,118 $535,000
Q3 2021 Oct 26, 2021	BUY	$81.78 - $95.14 $39,172 - $45,572	479 Added 8.54%	6,091 $498,000
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $180,197 - $199,033	2,114 Added 60.43%	5,612 $512,000
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $9,101 - $10,733	-109 Reduced 3.02%	3,498 $299,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $283,784 - $343,253	-3,635 Reduced 50.19%	3,607 $341,000
Q3 2020 Nov 05, 2020	BUY	$82.14 - $91.0 $594,857 - $659,022	7,242 New	7,242 $630,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $266,072 - $372,772	-3,765 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$84.35 - $95.37 $317,577 - $359,068	3,765 New	3,765 $357,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Novartis Ag Transaction History